The Trump administration delivered on its promise to protect children from experimental transgender procedures by unveiling sweeping federal funding cuts that will effectively end gender-affirming care for minors across America.
Story Highlights
- HHS announces federal Medicaid and Medicare funding cuts for hospitals providing transgender treatments to children
- Health Secretary RFK Jr. calls gender-affirming procedures “malpractice” that robs children of their futures
- New rules target nearly two dozen states where such treatments remain legal and federally funded
- FDA issues warning letters to companies marketing chest-binding equipment to minors
- Supreme Court’s Tennessee decision strengthens legal foundation for restricting transgender care
Administration Takes Decisive Action Against Child Gender Procedures
The U.S. Department of Health and Human Services announced Thursday the most comprehensive federal restrictions on transgender medical interventions for minors in American history.
Health Secretary Robert F. Kennedy Jr. condemned these procedures as “malpractice,” declaring that “sex-rejecting procedures rob children of their futures.”
The proposals include cutting federal Medicaid and Medicare funding from hospitals providing gender-affirming care to children and prohibiting federal Medicaid dollars from funding such procedures. This represents the administration’s most decisive move yet to protect vulnerable children from irreversible medical decisions.
Trump administration unveils proposals to cut off transgender care for minors https://t.co/dYcUQa635D
— CBS Mornings (@CBSMornings) December 18, 2025
Federal Funding Leverage Creates Nationwide Impact
The administration’s strategy targets the financial lifeline of American healthcare by threatening to withhold Medicare and Medicaid funding from non-compliant hospitals.
Nearly all U.S. hospitals depend on these federal programs, which cover seniors, disabled Americans, and low-income families. Losing access to these payments would financially devastate most medical providers, creating powerful incentives to cease transgender treatments for minors.
The restrictions also apply to the State Children’s Health Insurance Program for patients under 19. This approach effectively bypasses state-level resistance by using federal spending power to enforce child protection standards nationwide.
Medical Establishment Pushback Reveals Ideological Divide
While major medical organizations oppose the restrictions, polling shows approximately half of Americans support Trump’s handling of transgender issues. Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, characterized transgender treatments as “a Band-Aid on a much deeper pathology,” suggesting children with gender dysphoria are “confused, lost, and need help.”
Conservative activist Chloe Cole, who reversed her gender transition, praised the administration for finally hearing “cries for help” from detransitioners.
The medical establishment’s resistance highlights the ideological capture of healthcare institutions that prioritize progressive politics over protecting children from experimental procedures.
Building on the Constitutional Foundation for Child Protection
These healthcare restrictions build upon President Trump’s broader executive actions recognizing only two biological sexes and protecting women’s sports. The Supreme Court’s recent decision upholding Tennessee’s ban on transgender treatments for minors provides strong legal precedent for federal action.
Tennessee’s law prohibits puberty blockers and hormone therapy for transgender adolescents under 18, with the state arguing a “compelling interest in encouraging minors to appreciate their sex.”
The FDA simultaneously issued warning letters to companies marketing chest-binding equipment, stating that such products require FDA approval for medical uses. This coordinated approach demonstrates the administration’s commitment to using all available federal tools to protect children.
Long-Term Impact on American Family Values
While the proposed rules must undergo public comment periods and face likely legal challenges, many hospitals have already ceased providing transgender treatments in anticipation of federal action.
The administration’s exclusion of gender dysphoria from federal disability definitions further reinforces the traditional understanding of biological reality. With 27 states already restricting or banning such care, federal funding restrictions create a unified national standard protecting children from irreversible medical interventions.
This represents a crucial victory for parental rights and common-sense child protection policies that prioritize long-term well-being over ideological experimentation on vulnerable minors.
